{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:22:27Z","timestamp":1788398547175,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["Katherine Dodd Faculty Scholar Program"],"award-info":[{"award-number":["Katherine Dodd Faculty Scholar Program"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL123938"],"award-info":[{"award-number":["K23HL123938"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00246-018-2042-1","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T13:56:02Z","timestamp":1544709362000},"page":"650-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Practice Variation, Costs and Outcomes Associated with the Use of Inhaled Nitric Oxide in Pediatric Heart Transplant Recipients"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1325-4814","authenticated-orcid":false,"given":"David W.","family":"Bearl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Thurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7068-0625","authenticated-orcid":false,"given":"Justin","family":"Godown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"issue":"4","key":"2042_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.healun.2014.02.027","volume":"33","author":"J Kobashigawa","year":"2014","unstructured":"Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M et al (2014) Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant 33(4):327\u2013340. \n                    https:\/\/doi.org\/10.1016\/j.healun.2014.02.027","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"2042_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.healun.2003.08.001","volume":"23","author":"J Huang","year":"2004","unstructured":"Huang J, Trinkaus K, Huddleston CB, Mendeloff EN, Spray TL, Canter CE (2004) Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. J Heart Lung Transplant 23(6):716\u2013722. \n                    https:\/\/doi.org\/10.1016\/j.healun.2003.08.001","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"2042_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jtcvs.2009.08.020","volume":"139","author":"A Hoskote","year":"2010","unstructured":"Hoskote A, Carter C, Rees P, Elliott M, Burch M, Brown K (2010) Acute right ventricular failure after pediatric cardiac transplant: predictors and long-term outcome in current era of transplantation medicine. J Thorac Cardiovasc Surg 139(1):146\u2013153. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2009.08.020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2042_CR4","doi-asserted-by":"publisher","unstructured":"Davies RR, Russo MJ, Mital S, Martens TM, Sorabella RS, Hong KN, Gelijns AC, Moskowitz AJ, Quaegebeur JM, Mosca RS, Chen JM (2008) Predicting survival among high-risk pediatric cardiac transplant recipients: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 135(1):147\u2013155, 155 e141\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2007.09.019\n                    \n                  .","DOI":"10.1016\/j.jtcvs.2007.09.019"},{"issue":"4","key":"2042_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00246-012-0172-4","volume":"33","author":"PA Checchia","year":"2012","unstructured":"Checchia PA, Bronicki RA, Goldstein B (2012) Review of inhaled nitric oxide in the pediatric cardiac surgery setting. Pediatr Cardiol 33(4):493\u2013505. \n                    https:\/\/doi.org\/10.1007\/s00246-012-0172-4","journal-title":"Pediatr Cardiol"},{"issue":"8","key":"2042_CR6","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/phar.1959","volume":"37","author":"LA Sabato","year":"2017","unstructured":"Sabato LA, Salerno DM, Moretz JD, Jennings DL (2017) Inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction after left ventricular assist device placement and cardiac transplantation. Pharmacotherapy 37(8):944\u2013955. \n                    https:\/\/doi.org\/10.1002\/phar.1959","journal-title":"Pharmacotherapy"},{"key":"2042_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.niox.2015.06.002","volume":"49","author":"M Benedetto","year":"2015","unstructured":"Benedetto M, Romano R, Baca G, Sarridou D, Fischer A, Simon A, Marczin N (2015) Inhaled nitric oxide in cardiac surgery: evidence or tradition? Nitric Oxide 49:67\u201379. \n                    https:\/\/doi.org\/10.1016\/j.niox.2015.06.002","journal-title":"Nitric Oxide"},{"issue":"6","key":"2042_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.healun.2010.12.007","volume":"30","author":"G Ofori-Amanfo","year":"2011","unstructured":"Ofori-Amanfo G, Hsu D, Lamour JM, Mital S, O\u2019Byrne ML, Smerling AJ, Chen JM, Mosca R, Addonizio LJ (2011) Heart transplantation in children with markedly elevated pulmonary vascular resistance: impact of right ventricular failure on outcome. J Heart Lung Transplant 30(6):659\u2013666. \n                    https:\/\/doi.org\/10.1016\/j.healun.2010.12.007","journal-title":"J Heart Lung Transplant"},{"key":"2042_CR9","doi-asserted-by":"publisher","first-page":"656984","DOI":"10.1155\/2010\/656984","volume":"2010","author":"B Daftari","year":"2010","unstructured":"Daftari B, Alejos JC, Perens G (2010) Initial experience with sildenafil, bosentan, and nitric oxide for pediatric cardiomyopathy patients with elevated pulmonary vascular resistance before and after orthotopic heart transplantation. J Transplant 2010:656984. \n                    https:\/\/doi.org\/10.1155\/2010\/656984","journal-title":"J Transplant"},{"issue":"21","key":"2042_CR10","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","volume":"132","author":"SH Abman","year":"2015","unstructured":"Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK et al (2015) Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation 132(21):2037\u20132099. \n                    https:\/\/doi.org\/10.1161\/CIR.0000000000000329","journal-title":"Circulation"},{"issue":"1","key":"2042_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1060028015608865","volume":"50","author":"K McGinn","year":"2016","unstructured":"McGinn K, Reichert M (2016) A comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery. Ann Pharmacother 50(1):22\u201326. \n                    https:\/\/doi.org\/10.1177\/1060028015608865","journal-title":"Ann Pharmacother"},{"key":"2042_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2017.08.014","volume":"194","author":"J Godown","year":"2017","unstructured":"Godown J, Thurm C, Dodd DA, Soslow JH, Feingold B, Smith AH, Mettler BA, Thompson B, Hall M (2017) A unique linkage of administrative and clinical registry databases to expand analytic possibilities in pediatric heart transplantation research. Am Heart J 194:9\u201315. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2017.08.014","journal-title":"Am Heart J"},{"issue":"4","key":"2042_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/01.CIR.76.4.819","volume":"76","author":"SJ Bhatia","year":"1987","unstructured":"Bhatia SJ, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ, Young PJ, Mudge GH Jr, Sutton MG (1987) Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 76(4):819\u2013826","journal-title":"Circulation"},{"issue":"6","key":"2042_CR14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.athoracsur.2006.06.081","volume":"82","author":"I George","year":"2006","unstructured":"George I, Xydas S, Topkara VK, Ferdinando C, Barnwell EC, Gableman L, Sladen RN, Naka Y, Oz MC (2006) Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg 82(6):2161\u20132169. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2006.06.081","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"2042_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0022-5223(94)70273-8","volume":"107","author":"N Fukushima","year":"1994","unstructured":"Fukushima N, Gundry SR, Razzouk AJ, Bailey LL (1994) Risk factors for graft failure associated with pulmonary hypertension after pediatric heart transplantation. J Thorac Cardiovasc Surg 107(4):985\u2013989. \n                    https:\/\/doi.org\/10.1016\/S0022-5223(94)70273-8","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2042_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.healun.2011.08.021","volume":"31","author":"P Chiu","year":"2012","unstructured":"Chiu P, Russo MJ, Davies RR, Addonizio LJ, Richmond ME, Chen JM (2012) What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation. J Heart Lung Transplant 31(1):61\u201366. \n                    https:\/\/doi.org\/10.1016\/j.healun.2011.08.021","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"2042_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1399-3046.2012.01678.x","volume":"16","author":"S Buddhe","year":"2012","unstructured":"Buddhe S, Du W, L\u2019Ecuyer T (2012) Impact of pulmonary hypertension on transplant outcomes in pediatric cardiomyopathy patients. Pediatr Transplant 16(4):367\u2013372. \n                    https:\/\/doi.org\/10.1111\/j.1399-3046.2012.01678.x","journal-title":"Pediatr Transplant"},{"issue":"6","key":"2042_CR18","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/S0041-1345(99)00437-6","volume":"31","author":"MJ Paniagua","year":"1999","unstructured":"Paniagua MJ, Crespo-Leiro MG, Rodriguez JA, Fojon S, Pastor J, Castro MJ, Hermida LF, Cuenca JJ, Juffe-Stein A, Castro-Beiras A (1999) Usefulness of nitric oxide inhalation for management of right ventricular failure after heart transplantation in patients with pretransplant pulmonary hypertension. Transplant Proc 31(6):2505\u20132506","journal-title":"Transplant Proc"},{"issue":"4","key":"2042_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/00007890-200108270-00013","volume":"72","author":"A Ardehali","year":"2001","unstructured":"Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, Laks H (2001) Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 72(4):638\u2013641","journal-title":"Transplantation"},{"issue":"3","key":"2042_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.healun.2014.04.021","volume":"34","author":"ME Richmond","year":"2015","unstructured":"Richmond ME, Law YM, Das BB, Everitt MD, Kukreja M, Naftel DC et al (2015) Elevated pre-transplant pulmonary vascular resistance is not associated with mortality in children without congenital heart disease: a multicenter study. J Heart Lung Transplant 34(3):448\u2013456. \n                    https:\/\/doi.org\/10.1016\/j.healun.2014.04.021","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"2042_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","volume":"36","author":"LH Lund","year":"2017","unstructured":"Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ et al (2017) The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant 36(10):1037\u20131046. \n                    https:\/\/doi.org\/10.1016\/j.healun.2017.07.019","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"2042_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MAT.0000000000000524","volume":"63","author":"CR Villa","year":"2017","unstructured":"Villa CR, Khan MS, Zafar F, Morales DLS, Lorts A (2017) United States trends in pediatric ventricular assist implantation as bridge to transplantation. ASAIO J 63(4):470\u2013475. \n                    https:\/\/doi.org\/10.1097\/MAT.0000000000000524","journal-title":"ASAIO J"},{"key":"2042_CR23","doi-asserted-by":"publisher","unstructured":"Tsukashita M, Takayama H, Takeda K, Han J, Colombo PC, Yuzefpolskaya M, Topkara VK, Garan AR, Mancini DM, Kurlansky PA, Naka Y (2015) Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. J Thorac Cardiovasc Surg 150(5):1352\u20131360, 1361 e1351\u20131352. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2015.07.012","DOI":"10.1016\/j.jtcvs.2015.07.012"},{"key":"2042_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004515","author":"AC Egbe","year":"2017","unstructured":"Egbe AC, Connolly HM, Miranda WR, Ammash NM, Hagler DJ, Veldtman GR, Borlaug BA (2017) Hemodynamics of Fontan failure: the role of pulmonary vascular disease. Circ Heart Fail. \n                    https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004515","journal-title":"Circ Heart Fail"},{"issue":"5","key":"2042_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jtcvs.2004.07.013","volume":"128","author":"MB Mitchell","year":"2004","unstructured":"Mitchell MB, Campbell DN, Ivy D, Boucek MM, Sondheimer HM, Pietra B, Das BB, Coll JR (2004) Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg 128(5):693\u2013702. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2004.07.013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"2042_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00134-005-2675-4","volume":"31","author":"P Germann","year":"2005","unstructured":"Germann P, Braschi A, Della Rocca G, Dinh-Xuan AT, Falke K, Frostell C et al (2005) Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 31(8):1029\u20131041. \n                    https:\/\/doi.org\/10.1007\/s00134-005-2675-4","journal-title":"Intensive Care Med"},{"key":"2042_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002202","author":"J Godown","year":"2018","unstructured":"Godown J, Thurm C, Hall M, Soslow JH, Feingold B, Mettler BA, Smith AH, Bearl DW, Dodd DA (2018) Changes in pediatric heart transplant hospitalization costs over time. Transplantation. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000002202","journal-title":"Transplantation"},{"issue":"2","key":"2042_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1542\/peds.114.2.417","volume":"114","author":"SA Lorch","year":"2004","unstructured":"Lorch SA, Cnaan A, Barnhart K (2004) Cost-effectiveness of inhaled nitric oxide for the management of persistent pulmonary hypertension of the newborn. Pediatrics 114(2):417\u2013426","journal-title":"Pediatrics"},{"issue":"1","key":"2042_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/2045-8932.94835","volume":"2","author":"AT Brown","year":"2012","unstructured":"Brown AT, Gillespie JV, Miquel-Verges F, Holmes K, Ravekes W, Spevak P et al (2012) Inhaled epoprostenol therapy for pulmonary hypertension: improves oxygenation index more consistently in neonates than in older children. Pulm Circ 2(1):61\u201366. \n                    https:\/\/doi.org\/10.4103\/2045-8932.94835","journal-title":"Pulm Circ"},{"issue":"6","key":"2042_CR30","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1067\/mpd.2002.129849","volume":"141","author":"LK Kelly","year":"2002","unstructured":"Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH (2002) Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. The J Pediatr 141(6):830\u2013832. \n                    https:\/\/doi.org\/10.1067\/mpd.2002.129849","journal-title":"The J Pediatr"},{"issue":"4","key":"2042_CR31","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","volume":"127","author":"CJ De Wet","year":"2004","unstructured":"De Wet CJ, Affleck DG, Jacobsohn E, Avidan MS, Tymkew H, Hill LL, Zanaboni PB, Moazami N, Smith JR (2004) Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 127(4):1058\u20131067. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2003.11.035","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2042_CR32","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/01.CIR.103.4.544","volume":"103","author":"PC Rimensberger","year":"2001","unstructured":"Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103(4):544\u2013548","journal-title":"Circulation"},{"issue":"3","key":"2042_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijcard.2007.08.084","volume":"129","author":"A Limsuwan","year":"2008","unstructured":"Limsuwan A, Wanitkul S, Khosithset A, Attanavanich S, Samankatiwat P (2008) Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease. Int J Cardiol 129(3):333\u2013338. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2007.08.084","journal-title":"Int J Cardiol"},{"issue":"10","key":"2042_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1399-6576.2006.01139.x","volume":"50","author":"K Theodoraki","year":"2006","unstructured":"Theodoraki K, Tsiapras D, Tsourelis L, Zarkalis D, Sfirakis P, Kapetanakis E, Alivizatos P, Antoniou T (2006) Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction. Acta Anaesthesiol Scand 50(10):1213\u20131217. \n                    https:\/\/doi.org\/10.1111\/j.1399-6576.2006.01139.x","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"2042_CR35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S1053-0770(96)80047-4","volume":"10","author":"A Haraldsson","year":"1996","unstructured":"Haraldsson A, Kieler-Jensen N, Ricksten SE (1996) Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 10(7):864\u2013868","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"2042_CR36","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jtcvs.2009.04.063","volume":"138","author":"TA Khan","year":"2009","unstructured":"Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A (2009) A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg 138(6):1417\u20131424. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2009.04.063","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"2042_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s00380-017-1023-2","volume":"32","author":"K Theodoraki","year":"2017","unstructured":"Theodoraki K, Thanopoulos A, Rellia P, Leontiadis E, Zarkalis D, Perreas K, Antoniou T (2017) A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension. Heart Vessels 32(12):1488\u20131497. \n                    https:\/\/doi.org\/10.1007\/s00380-017-1023-2","journal-title":"Heart Vessels"},{"issue":"6","key":"2042_CR38","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ejcts.2007.02.019","volume":"31","author":"Y Lamarche","year":"2007","unstructured":"Lamarche Y, Perrault LP, Maltais S, Tetreault K, Lambert J, Denault AY (2007) Preliminary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg 31(6):1081\u20131087. \n                    https:\/\/doi.org\/10.1016\/j.ejcts.2007.02.019","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-2042-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-018-2042-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-2042-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T05:45:57Z","timestamp":1589694357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-018-2042-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1007\/s00246-018-2042-1","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data reported here have been supplied by the Minneapolis Medical Research Foundation as the contractor for the SRTR. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy of or interpretation by the SRTR or the U.S. Government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study formal consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informal Consent"}}]}}